Does GEHA Cover Wegovy? Yes — But What You Pay Changed on January 1, 2026

By The RX Index · Last verified: August 19, 2026

Affiliate disclosure: The RX Index may earn a commission from some links on this page. It never changes what GEHA or CVS Caremark covers. Links to GEHA, CVS Caremark, Novo Nordisk, and government tools are not affiliate links.

Does GEHA cover Wegovy in 2026? Yes. GEHA covers the standard weekly Wegovy injection on all eight of its regular FEHB and PSHB plan options when prior authorization is approved. On January 1, 2026, Wegovy moved from preferred to non-preferred on High, Standard, HDHP, and Elevate Plus. It stayed preferred on Elevate. What you pay at the pharmacy changed.

That's the answer. Here's the part almost nobody tells you: on GEHA's cheapest FEHB plan, Wegovy is still preferred. And on GEHA High, your third 30-day retail fill of a maintenance drug can cost more than the first two — for the exact same prescription.

We'll show you both, with the numbers.

Branded-Wegovy scope: Wegovy injection, Wegovy HD 7.2 mg injection, and Wegovy tablets are FDA-approved brand-name products. Compounded semaglutide is not Wegovy, is not an FDA-approved generic, and is not FDA-approved. The coverage rules below are for branded Wegovy.

Your GEHA plan, at a glance

Source: GEHA, Pharmacy coverage for weight loss GLP-1 medications, document FE-WEB-1225-001. Retrieved August 19, 2026.

This page is for you if: you carry a GEHA card, you take or want to take Wegovy, and you want to know what it costs and how to get approved.

This page is not for you if: you're trying to pick a telehealth company to prescribe it. Start with GLP-1 Providers That Accept GEHA instead. If you're asking whether Wegovy is medically right for you, that's a conversation for your doctor, not an article.

The RX Index is the independent GLP-1 decision resource that scores telehealth providers and treatment paths on clinical legitimacy, care quality, transparency, access, and cost, so readers can choose the path that fits their situation.

📋 What we actually verified

On August 19, 2026, we read these documents ourselves:

• GEHA's 2026 weight-loss GLP-1 coverage FAQ, document FE-WEB-1225-001
• GEHA's 2026 FEHB and PSHB plan pages and official plan brochures — all eight regular plan options
• The current traditional and value formularies that show which Wegovy forms are listed
• The current publicly posted CVS Caremark Wegovy criteria document, 4774-C, P08-2025 v4
• GEHA's appeal and disputed-claims process
• Novo Nordisk's Wegovy savings-offer terms and official self-pay prices
• GEHA's SilverScript Medicare prescription-drug information
• CMS's Medicare GLP-1 Bridge pages and prescriber instructions
• OPM's rule for the annual Open Season dates

Then we did the math ourselves to build the cost tables below. GEHA publishes the tier. GEHA publishes the cost formula. The tables below join the two so you can see the result in one place.

Provider-stated versus independently checked

What we can't tell you: the exact dollar amount your pharmacy will ring up. GEHA's Check Drug Costs tool gives a plan-specific estimate, and your processed claim is the final number. We'll show you how to get that estimate in about 90 seconds.

Does GEHA cover Wegovy in 2026?

Yes. GEHA's own 2026 coverage document states that Wegovy is covered for members who meet the prior authorization requirements. The standard weekly injection is non-preferred on High, Standard, HDHP, and Elevate Plus, and preferred on Elevate. Prior authorization is required before the plan will pay.

GEHA publishes a short two-page PDF that answers this question directly. It's public. It's linked from GEHA's own prescription page. It carries the ID FE-WEB-1225-001. And in it, GEHA writes plainly that yes, Wegovy will be covered in 2026 for members who meet the prior authorization requirements.

The form matters. The current traditional formulary used by High, Standard, HDHP, and Elevate Plus lists the standard injection, Wegovy HD 7.2 mg, and Wegovy tablets as Tier 3 with prior authorization. Elevate's current value formulary lists the standard injection. Search the exact form, strength, and product before you count on coverage.

Three different questions people mean by “covered”

This trips up almost everyone. “Covered” is really three separate questions, and you can pass one and fail another.

Most of the confusion online comes from mixing up question one and question three. Wegovy is covered. That does not mean it's cheap.

Three words that decide your bill

• Preferred — the plan gives the drug a better spot on its list. You usually pay less.
• Non-preferred — still covered, but a worse spot. You usually pay more.
• Non-formulary — not on the normal list. The plan pays only if your doctor wins a special exception.

And two terms that get mixed up constantly:

• Prior authorization (PA) — your prescriber shows that you meet the rules for a drug that is on the formulary.
• Formulary exception — your prescriber asks the plan to cover a drug that is not on the formulary and shows why the formulary choices do not work for you. This is a harder review.

Wegovy needs a prior authorization. Zepbound needs a formulary exception. That difference matters a lot, and we'll come back to it.

What changed for GEHA Wegovy coverage on January 1, 2026?

Wegovy moved from preferred to non-preferred on GEHA's High, Standard, HDHP, and Elevate Plus plans effective January 1, 2026. It stayed preferred on Elevate. Saxenda moved the same way. GEHA's published change was the cost tier; prior authorization still applies.

Here's the before and after, straight from GEHA's document:

Source: GEHA document FE-WEB-1225-001.

The Elevate surprise

Read that last row again. Elevate is GEHA's lowest-premium FEHB plan — $77.92 biweekly for Self Only — and it's the only 2026 plan where the standard Wegovy injection is still preferred.

That runs against everything people assume about insurance. Cheap plan, worse drug coverage, right? Not here. Not for this drug.

Before you go switch plans over it, read the Open Season section further down. Elevate has real trade-offs, and we're not going to pretend otherwise.

🔻 The honest catch

We need to be straight with you about the limit of what any website can tell you.

We can tell you your tier and your cost formula, because GEHA publishes both. We cannot promise the price your pharmacy will ring up. GEHA calls its own tool an estimate. The processed claim controls.

On three plan options it's harder than that. FEHB HDHP, PSHB HDHP, and Elevate Plus publish no dollar maximum for a non-preferred retail drug. There is no ceiling in the published cost-share row.

So we built the next best thing — and honestly, a more useful thing. Below you'll find the published maximum for every plan that has one, the price point where each maximum takes over, the High plan retail-fill trap, and a 90-second method to pull your own plan estimate. Below are four practical ways to lower your bill, each beginning with a step you can take today.

How much does Wegovy cost with GEHA in 2026?

There is no single GEHA Wegovy price. Each plan uses a different formula. FEHB High publishes 40% up to $400 for a 30-day non-preferred retail drug. FEHB Standard publishes 60% up to $550. Elevate publishes 50% up to $500 for a preferred retail drug. FEHB HDHP, PSHB HDHP, and Elevate Plus publish a percentage with no dollar maximum in that row.

This is the table we built. It joins GEHA's tier document to GEHA's published cost-share grid across all eight regular FEHB and PSHB plans.

The 2026 GEHA Wegovy cost ladder

Standard weekly injection; 30-day supply at an in-network retail pharmacy. The Caremark estimate and processed claim control.

Sources: GEHA's 2026 FEHB and PSHB plan pages and brochures. Retrieved August 19, 2026. These are published formulas, not a guaranteed Wegovy price.

Three things jump out of that table.

1. PSHB High and Standard publish lower maxima for this tier. PSHB High's 30-day non-preferred maximum is $300; FEHB High's is $400. PSHB Standard's is $450; FEHB Standard's is $550. Same company, same drug tier, a $100 difference in each pair.

2. Elevate Plus took the hardest tier hit. On Elevate Plus, a preferred brand-name drug is a flat $100 copay. A non-preferred one is 50% coinsurance with no published dollar maximum. One tier move pulled Wegovy out of the $100 lane on GEHA's highest-premium FEHB plan for Self Only at $205.13 biweekly.

3. Three plan options publish no dollar maximum. If you're on FEHB HDHP, PSHB HDHP, or Elevate Plus, you have to pull your own estimate. The percentage alone is not enough.

When does the published maximum take over?

Coinsurance is a percentage of the plan's allowed amount. You can work out the point where the percentage reaches the maximum.

Our calculation from the published rates and maxima: divide the maximum by the rate.

This table does not prove your claim will hit the maximum. It tells you how to read the Caremark result. If the plan's allowed amount is above the breakpoint, the published maximum should be the controlling plan amount before any valid savings offer. If it is below the breakpoint, you pay the percentage.

➡️ Your next step, and it's free: Find your plan name on your GEHA card, then use GEHA's official Check Drug Costs page. FEHB members should open the FEHB tool. Postal members should open the PSHB tool. GEHA says the result is an estimate for your chosen plan, retail, and mail service — not a guarantee from a stranger's website.

Why can GEHA High cost more after two 30-day retail fills?

On GEHA High — FEHB and PSHB — the normal 30-day retail amount applies to the first two fills of a maintenance drug. For the third and later 30-day retail fills outside Maintenance Choice, the brochure says you pay the greater of 50% of the plan allowance or the normal cost share. GEHA's stated route around that rule is a 90-day maintenance fill through mail service or an eligible CVS retail pharmacy.

This is buried in a footnote, and it's the single most expensive thing many High members don't know.

Wegovy is usually used as a long-term medication. If your prescription is treated as a maintenance drug and you keep using 30-day retail fills, the third fill is where the rule can bite.

GEHA isn't hiding the fix. It's printed right there in the same footnote: use Maintenance Choice, which can include mail service or a 90-day supply at an eligible CVS Pharmacy store.

So let's price out the published maxima, without pretending every claim hits them.

The 90-day move

Monthly equivalent = the 90-day published maximum divided by 3.

Our calculation from GEHA's published 30-day and 90-day cost shares. Savings occur only if the exact product is eligible for a 90-day fill and the compared claims reach the shown maxima.

For a FEHB Standard member whose claims hit the published maxima all year, the 90-day maximum is up to $2,200 lower over four 90-day fills than twelve 30-day retail maxima. For FEHB High, the same maximum-only comparison is up to $1,600 lower, and it also avoids the third-and-later retail formula. PSHB Standard's maximum-only difference is up to $1,800 a year.

Elevate members can't make this move at all. Elevate has no mail-order pharmacy benefit and a limited pharmacy network. That's the trade-off hiding inside the “Wegovy is still preferred” headline.

One caution before you call: a plan offering 90-day mail service doesn't automatically prove your exact Wegovy form and dose can ship that way. Ask Caremark to confirm the exact product, quantity, days supply, and pharmacy before you switch.

Can I use the $25 Wegovy savings offer with GEHA?

If you have regular FEHB prescription coverage and are not using Medicare, you may qualify under Novo Nordisk's other terms. Novo's terms say the Federal Employees Health Benefits Program is not treated as a government health care program for this offer. The one-month savings cap is $100, so “as little as $25” happens only when your eligible share is $125 or less.

This is where a lot of federal employees get bad information, so here it is straight from the manufacturer.

Novo Nordisk's terms say the Federal Employees Health Benefits Program, ACA marketplace plans, and state employee plans are not federal or state government health care programs for this offer. Medicare, Medicaid, TRICARE, VA, and other government-funded drug coverage are excluded.

The part the ads don't emphasize

The offer is advertised as “pay as little as $25.” The fine print sets these maximum savings amounts:

So the card can subtract up to $100 per month. It does not simply reset every claim to $25.

What the full $100 would do on capped FEHB claims

Our calculation. Your actual eligible savings can be lower, and HDHP or Elevate Plus require the plan-specific estimate because they have no published retail maximum for this tier.

Still worth doing. $100 a month is up to $1,200 a year. Just don't budget for $25 and get surprised.

Two honest limits. First, Novo's current terms name FEHB, but they do not name the newer PSHB program. A PSHB member should have the pharmacy run the offer and confirm eligibility before budgeting on it. Second, the terms allow up to $300 on an eligible three-month claim, but your exact Wegovy product still has to be eligible for that days supply.

The terms also warn that some plan designs may not count all manufacturer assistance toward your deductible or out-of-pocket limit. Check the claim after it processes instead of assuming.

➡️ Do this before your next fill, not after. Enroll through Novo Nordisk's official Wegovy savings-offer page and take the information to the pharmacy. Novo says fills made before enrollment are not eligible for reimbursement. It's free and takes a few minutes.

Is it ever cheaper to skip GEHA and pay cash for Wegovy?

On some claims, yes. Novo Nordisk offers set self-pay prices for branded Wegovy. If your Caremark estimate after any valid savings offer is above the matching manufacturer self-pay price, cash is cheaper for that fill. But cash payments do not count toward your plan deductible or out-of-pocket maximum, so the cheaper month is not always the cheaper year.

Here's the comparison nobody publishes.

Novo Nordisk self-pay prices, verified August 19, 2026:

• Standard Wegovy pen: $199 per 28-day fill for an eligible new patient's first two fills at the 0.25 mg and 0.5 mg starting doses through December 31, 2026, then $349 per 28-day fill
• Wegovy HD 7.2 mg: $399 per 28-day fill
• Wegovy tablets: $149 for 1.5 mg; $149 for 4 mg through August 31, 2026, then $199; and $299 for 9 mg or 25 mg

Manufacturer terms and eligibility rules apply. Prices can change, which is why the verification date matters.

Insurance versus cash: the honest decision rule

What happens in a worst-case capped FEHB month?

This table is a scenario, not a promise that your claim hits the maximum.

The uncomfortable part: if a FEHB Standard or Elevate claim reaches the plan maximum, even the full one-month savings amount can leave branded Wegovy more expensive than buying the standard pen straight from the manufacturer.

The part that flips it back: a covered insurance claim can count toward your plan's out-of-pocket maximum and, when the deductible applies to that claim, toward the deductible. Novo's self-pay terms say its self-pay purchase is outside insurance and does not count toward either.

GEHA publishes these 2026 in-network Self Only figures:

So the real rule is simple:

• If Wegovy is basically your only covered health expense this year — cash may genuinely win on some claims. Do the math.
• If you expect major covered medical or pharmacy spending — count the value of out-of-pocket credit and any deductible credit that applies before you give it up.
• If you're on FEHB Standard or High — compare a confirmed 90-day estimate first. The published 90-day maximum can beat cash, but only if your exact product can be filled that way.

➡️ If your Caremark estimate after any valid savings is already below the matching cash price, stop reading and go fill it. Seriously. You don't need us, you don't need a telehealth company, and you don't need to keep researching. That's the win. Come back if something changes.

How do I get Wegovy approved through GEHA?

GEHA's pharmacy benefit is administered by CVS Caremark, so your prescriber sends the prior-authorization request through Caremark. The current publicly posted Caremark policy has four approval paths. For adult weight management, it requires at least six months in a comprehensive program that includes behavior change, a reduced-calorie diet, increased physical activity, and continuing follow-up before drug therapy.

The current public criteria document is Caremark's 4774-C, P08-2025 v4. We read it end to end. Here's what it asks for, in plain English.

The four doors

Source: CVS Caremark, Wegovy Prior Authorization with Limit, document 4774-C, P08-2025 v4. This is the current publicly posted Caremark policy we found. Confirm the exact version applied to your GEHA request with Caremark at 1-844-443-4279; your approval or denial notice controls your case.

Three details worth real money

1. The six-month program requirement is the easiest one to miss. It has to happen before drug therapy, and it has to be documented. The public policy does not name a paid commercial program. It does require the record to show all four pieces: behavior change, a reduced-calorie diet, increased physical activity, and continuing follow-up for at least six months. The word that matters is documented. If your doctor has been talking to you about weight for a year but the chart does not show those pieces, that's the gap to close first.

2. If you're switching from another weight-loss medication, your starting BMI is measured from when you began any drug therapy — not only from today. The criteria say so explicitly. So if you've already lost weight on something else and you're below the starting cutoff now, the earlier number may matter. Make sure your prescriber sends that number with the date.

3. The heart-disease path lasts 12 months instead of 8 or 6. If you meet that separate path, that's a longer first approval window before renewal.

Renewing your approval

For weight-management continuation, the public policy asks for at least three months at a stable maintenance dose plus documented weight loss of at least 5% from your starting weight — or proof you're holding that loss.

Two practical warnings. Approvals have end dates, and they don't renew themselves. And an approval for one form of Wegovy shouldn't be assumed to cover another. Check the product, strength, quantity, and end date in your Caremark account today, not the week your refill bounces.

What to hand your doctor's office

• The exact medication, form, strength, directions, quantity, and days supply
• The diagnosis and diagnosis codes used for the request
• Height, starting weight, current weight, and calculated BMI, each with dates
• Documentation of the 6-month comprehensive weight-management program when that path applies
• Chart notes that show every required part, not only demographic and drug information
• If switching from another weight-loss drug: the BMI and related condition at the start of any drug therapy
• For renewal: starting weight, current weight, the date you reached a stable maintenance dose, and proof of at least 5% loss or maintenance

Who's going to actually do this paperwork?

Fair question, and it's the point where a lot of people stall out.

For most GEHA members, start with your own doctor. That office may already have the six months of records Caremark wants. Ask directly: “Will you submit a prior authorization to CVS Caremark for this exact Wegovy product and attach the chart notes?”

GEHA also gives all medical members access to MDLIVE. Elevate, Standard, Elevate Plus, High, and Medicare-primary members pay $0 for a non-emergency medical visit. HDHP members pay the plan allowance before the deductible; after the deductible, GEHA says MDLIVE charges the visit and GEHA reimburses 100% of the plan allowance. MDLIVE does not promise that every clinician will prescribe Wegovy or manage a prior authorization, so ask before you book.

If neither route works for you — no regular prescriber, an office that won't take on prior authorizations, or you want a team built around the process — there's a paid option worth knowing about.

Ro's free GLP-1 Insurance Coverage Checker checks coverage for the Wegovy pen and sends a report. The free checker does not prescribe treatment and does not submit a prior authorization. If you enroll in Ro's care program and a Ro-affiliated clinician prescribes an appropriate branded drug, Ro says its insurance concierge checks coverage and submits required PA paperwork. Ro Body membership is $39 for the first month, then $74 per month with an annual plan paid upfront or $149 month-to-month. Medication is billed separately.

Ro's free checker currently says it cannot check coverage for the Wegovy pill. It also does not say that a pen report proves coverage for Wegovy HD. Search and request the exact product you intend to use.

→ Check Wegovy pen coverage with Ro's free insurance checker (affiliate link)

One thing we'll say plainly: the best outcome for most people reading this is that your own doctor submits the PA, it gets approved, and you fill it at your regular pharmacy with any savings offer you validly qualify for. That path earns this site nothing. We'd still rather you take it.

What if GEHA denies Wegovy, or the pharmacy says it's not covered?

Start by finding out which problem you actually have — a missing or expired prior authorization, incomplete clinical documentation, the wrong product on file, a quantity rule, or a pharmacy rule. GEHA states that prior-authorization decisions can be appealed and that an initial appeal may be filed within six months of the decision.

Not every “not covered” message means the same thing. Match yours before you do anything else.

These are troubleshooting categories we built from GEHA's and Caremark's published processes — not official denial codes.

Fix it before you appeal

An appeal is a formal process. A missing chart note is not. If the notice says information is missing, try this order first:

1. Get the exact denial reason in writing.
2. Ask which policy version and criterion were applied.
3. Compare what was submitted against the checklist above.
4. Have your prescriber correct or add the missing records.
5. Ask whether the request should be resubmitted, reconsidered, or formally appealed.

If you do need to appeal

GEHA's published process has three levels for its regular FEHB and PSHB coverage:

Level 1 — Initial appeal. You may appeal to GEHA within six months of the decision, by mail, online, or fax.

Level 2 — Reconsideration. GEHA reviews the dispute again and may consult a health care professional.

Level 3 — OPM review. If you still disagree, the U.S. Office of Personnel Management can review the claim. OPM sends a final decision or a status update within 60 days.

Send it to the right address — there are two, and this matters. A PA denial before you receive the drug is generally a pre-service dispute. Follow the address and deadline on your denial notice.

• Pre-service appeals: GEHA, P.O. Box 400046, San Antonio, TX 78229
• Post-service appeals: GEHA Post-Service Appeals, P.O. Box 21324, Eagan, MN 55121
• Fax: 1-866-963-0156
• Email for medical appeals: [email protected]
• Forms and online instructions: GEHA Appeals and Disputed Claims

Include: your name, member ID, date of birth, plan name, date of service, claim control number if one exists, billed amount if applicable, provider name, a clear description of the dispute, and supporting records such as the denial, physician letter, chart notes, and Explanation of Benefits.

Someone else can appeal for you if the required authorized-representative form is included.

Two timing notes. GEHA says it typically reviews post-service appeals within 30 days, while pre-service timing may vary. And if you exhaust the FEHB/PSHB process, GEHA says a lawsuit against OPM in federal court must be filed by December 31 of the third year after the year in which care or a drug was provided or denied.

If your drug coverage is through GEHA's SilverScript Medicare prescription plan, use the Part D appeal instructions on that denial notice. The regular GEHA-to-OPM path above is not the Medicare Part D appeal path.

➡️ Denied and not sure which path fits you? If you're weighing an appeal against a different medication, a different pharmacy, or cash while you sort it out, The RX Index's Find My GLP-1 Path tool walks you through the treatment paths and source-verified prices. No email required.

Does GEHA cover Zepbound, Saxenda, the Wegovy pill, or Wegovy HD?

Zepbound is non-formulary on every regular GEHA plan in 2026 and requires a formulary exception. Saxenda moved to non-preferred alongside the standard Wegovy injection on High, Standard, HDHP, and Elevate Plus. Generic liraglutide is listed with prior authorization. Wegovy tablets and Wegovy HD are listed on GEHA's current traditional formulary, but Elevate's current value formulary lists only the standard Wegovy injection.

Quick rundown from GEHA's coverage FAQ and current drug lists:

Why the Zepbound difference is a big deal. A prior authorization asks your prescriber to show you meet the rules for a listed drug. A formulary exception asks the plan to cover a drug that is not on the normal list. GEHA's definition says the review also asks whether other formulary drugs are clinically effective for you. That is a higher bar.

One caution on Wegovy specifically. “Wegovy” is no longer one product. It can mean the standard weekly injection, the higher-dose Wegovy HD injection, or a daily tablet. The current public Caremark policy gives different first-approval windows: 8 months for adult weight management with either injection, 6 months for tablets, and 7 months for ages 12–17 using the standard injection. Don't assume one approval covers another form. Search the exact product and strength in your Caremark account.

What if I'm Postal, retired, or on Medicare?

First look at the prescription card you use at the pharmacy. If it says SilverScript or GEHA Prescription Drug Plan/EGWP, the regular eight-plan tables above do not control your drug claim. You are using a Medicare Part D employer plan. Manufacturer savings offers are closed to Medicare beneficiaries, and the Medicare GLP-1 Bridge has its own strict rules.

Postal workers and annuitants use PSHB, not FEHB. GEHA offers three regular PSHB plan options — High, Standard, and HDHP. There is no PSHB Elevate or Elevate Plus.

There are four common GEHA situations, and they do not get the same answer.

GEHA says its Medicare Prescription Drug Plan/EGWP is offered by SilverScript. It says all GEHA PSHB retirees with Medicare Part A and/or B who live in the United States qualify, as do GEHA FEHB retirees in Standard or High with Medicare Part A and/or B. New members receive a separate prescription ID card.

If your drug card says SilverScript

The good news: GEHA publishes a $2,100 annual Part D out-of-pocket maximum for 2026 under its EGWP. That is a drug-only Part D number, not the $6,000–$10,600 combined regular-plan figures shown earlier.

The catch: do not use the regular FEHB or PSHB Wegovy cost ladder to predict your SilverScript claim. The EGWP has its own tiers, pharmacy rules, and cost shares. Check the exact product through the GEHA Prescription Drug Plan page or call SilverScript at 1-833-250-3241.

Can the Medicare GLP-1 Bridge cover Wegovy for $50?

Yes, but only if you meet the Bridge rules. The Medicare GLP-1 Bridge runs from July 1, 2026 through December 31, 2027. It covers eligible Wegovy injection and tablet claims for a $50 copay, outside the normal Part D payment flow. The $50 does not count toward your Part D deductible or true out-of-pocket spending.

CMS's current criteria require all of these basics:

• You have eligible Medicare Part D coverage.
• You are at least 18.
• The drug is for reducing excess body weight and maintaining weight loss, not another approved use.
• The prescription is used with ongoing structured nutrition and physical activity.
• You have not received a GLP-1 through your Part D plan during 2026 before entering the Bridge.
• You do not have type 2 diabetes, moderate-to-severe obstructive sleep apnea, or noncirrhotic MASH with moderate-to-advanced fibrosis (F2–F3).
• You meet one of the BMI-and-risk paths below.

CMS lists Foundayo tablets, Wegovy injection and tablets, and Zepbound KwikPen as Bridge drugs for weight management. The single-dose Zepbound pen and vials are not included in the prescriber instructions we reviewed.

Six catches CMS spells out:

1. If you received a GLP-1 through your Part D plan at any point in 2026 before entering the Bridge, CMS says the Bridge is not your route for 2026. Your request goes to the Part D plan.
2. The Bridge allows only 28-day or 30-day fills, not 90-day fills.
3. A prior authorization is still required. CMS says the pharmacy starts the Bridge claim, then the prescriber receives the PA request if the patient appears eligible.
4. You cannot stack another coupon, discount card, or manufacturer offer on top of the $50 Bridge copay.
5. The Part D low-income subsidy does not lower the $50 Bridge copay.
6. There is no formal Bridge appeal process. If the PA was denied because information was wrong or incomplete, CMS says the prescriber may submit a corrected request or add new information.

Once a Bridge PA is approved, CMS says later fills do not need another PA unless you switch to a different covered GLP-1. Current approvals run through December 31, 2027.

Source: CMS Medicare GLP-1 Bridge and CMS information for prescribers, retrieved August 19, 2026. Check possible eligibility at Medicare.gov or call 1-800-MEDICARE.

Should I switch GEHA plans over Wegovy at Open Season?

Possibly, but not on this drug alone. Elevate is the only 2026 FEHB plan where the standard Wegovy injection is still preferred. It also has no mail-order pharmacy, a limited pharmacy network, the highest Self Only out-of-pocket maximum among GEHA's FEHB plans, and a 100% cost share for non-preferred retail brand-name drugs. A plan picked for one drug can become the wrong plan when the formulary changes.

Under OPM's standing calendar rule, Open Season for 2027 coverage runs November 9 through December 14, 2026. Before you move, weigh the whole picture, not one tier.

All five 2026 FEHB plans, side by side

2026 figures from GEHA's published plan pages and brochures. Rates shown are the published employed Self Only amounts and may not apply to every enrollment category.

Read Elevate's non-preferred rule twice. Elevate wins the Wegovy tier comparison and can lose badly on another drug that lands non-preferred. If you or a family member takes any other brand-name medication, search every exact drug before you switch.

Also read the HDHP row twice. It has a higher deductible than Elevate, but GEHA puts $1,000 into a Self Only HSA. The right comparison is not premium alone or Wegovy alone. It is:

Annual premiums + expected medical spending + expected pharmacy spending − employer/plan HSA contribution − valid savings

And the honest caveat: Wegovy was preferred on four more plan names a year ago. Tiers move. Pick the plan that fits your whole household's health, then optimize the drug inside it.

How do I check my own GEHA Wegovy price in 90 seconds?

GEHA and CVS Caremark run a drug-cost tool tied to the plan you select. GEHA calls the result an estimate of what you should pay out of pocket. It supplies the missing plan-specific estimate for FEHB HDHP, PSHB HDHP, and Elevate Plus before a claim, because those plan rows publish no dollar maximum for non-preferred retail drugs.

Five steps. Do them before your next fill.

1. Find your plan and program. Check whether you have FEHB, PSHB, or a separate SilverScript Medicare prescription card.
2. Open the right tool. Use GEHA's Check Drug Costs page, then choose FEHB or PSHB. A SilverScript member should use the GEHA Prescription Drug Plan tools instead.
3. Search the exact product. Not only “semaglutide.” Search the standard Wegovy injection, Wegovy HD, or the tablet strength and days supply on your prescription.
4. Compare retail and mail when mail is allowed. On Standard and High, the published maxima can differ by hundreds of dollars over 90 days. Confirm that your exact product is eligible before counting any savings.
5. Open every plan note. Look for PA required, PA expiration date, quantity limits, pharmacy restrictions, mail eligibility, and any maintenance-fill rule.

Save a screenshot with the date. It is a record of the estimate you saw, not a guarantee of the final claim. If the pharmacy later charges something different, it gives Caremark a concrete result to compare.

When the estimate and the pharmacy claim disagree, call CVS Caremark at 1-844-443-4279 — that's the number GEHA gives members for weight-loss drug questions. Ask exactly this:

“I'm a GEHA member. For this exact Wegovy product on my plan, can you tell me the coverage status, tier, prior-authorization status, allowed amount, member cost, pharmacy restriction, quantity limit, and whether 30-day and 90-day fills are allowed?”

Then ask for a reference number and write it down.

For general GEHA questions, Customer Care is 1-800-821-6136. For GEHA SilverScript questions, call 1-833-250-3241.

Frequently asked questions

Does GEHA Standard cover Wegovy? Yes, with prior authorization. The standard injection is non-preferred on Standard in 2026. FEHB Standard publishes 60% with a $550 maximum for a 30-day non-preferred retail drug; PSHB Standard publishes 60% with a $450 maximum. Your Caremark estimate and processed claim control.

Does GEHA High cover Wegovy? Yes, with prior authorization, and the standard injection is non-preferred. FEHB High publishes 40% up to $400 for a normal 30-day retail claim; PSHB High publishes 40% up to $300. After two 30-day retail fills of a maintenance drug, the third and later fill can use the greater-of-50% rule unless you use the plan's Maintenance Choice route.

Does GEHA HDHP cover Wegovy? Yes, with prior authorization. The standard injection is non-preferred and the published cost share is 40% after the deductible, with no dollar maximum shown in that row. Both FEHB and PSHB HDHP publish a $1,800 Self Only deductible and a $1,000 GEHA HSA contribution.

Does GEHA Elevate cover Wegovy? Yes, with prior authorization, and Elevate is the one 2026 plan where the standard injection is still preferred. Elevate publishes 50% up to $500 for a 30-day preferred retail drug. Elevate has no mail-order pharmacy benefit and a limited pharmacy network.

Does GEHA Elevate Plus cover Wegovy? Yes, with prior authorization. The standard injection is non-preferred on Elevate Plus, which means 50% coinsurance with no dollar maximum shown in that row. That is a major change from the flat $100 copay for a preferred 30-day brand-name drug.

Does GEHA cover the Wegovy pill? GEHA's current traditional formulary lists Wegovy tablets at 1.5, 4, 9, and 25 mg as Tier 3 with prior authorization for High, Standard, HDHP, and Elevate Plus. Elevate's current value formulary does not list the tablets. Search the exact tablet strength before assuming.

Does GEHA cover Wegovy HD 7.2 mg? The current traditional formulary lists Wegovy HD 7.2 mg as Tier 3 with prior authorization. Elevate's current value formulary does not list it. The standard injection's coverage does not prove HD coverage.

How much is Wegovy with GEHA? There's no single answer. Use the cost ladder above to find your plan's formula, then pull the plan-specific estimate. Five regular plan options publish a 30-day dollar maximum from $300 to $550; FEHB HDHP, PSHB HDHP, and Elevate Plus do not publish one for this tier.

Can FEHB members use the Wegovy savings offer? Novo's current terms expressly say FEHB is not treated as a government health care program for the offer. You still must meet every other rule, and Medicare-based coverage is excluded. The maximum is $100 for one month, $200 for two months, or $300 for three months.

Can PSHB members use the Wegovy savings offer? Novo's current terms do not expressly name PSHB. Do not assume either answer. Have the pharmacy submit the offer and confirm the result before you budget on it. A PSHB retiree using SilverScript Medicare drug coverage is not eligible.

Does an old prior authorization carry to a new form, plan, or year? Don't assume it does. Check your approval letter and Caremark account for the plan, exact product, strength, quantity, and end date, and start a renewal before it lapses.

Does GEHA use CVS Caremark? Yes. CVS Caremark administers GEHA's regular pharmacy benefit, and SilverScript, which is affiliated with CVS Caremark, offers GEHA's Medicare Prescription Drug Plan/EGWP.

Can I appeal a Wegovy denial? Yes. GEHA says regular FEHB/PSHB PA decisions can be appealed, with the initial appeal filed within six months. Follow the deadline and address on your denial. SilverScript Medicare denials use the Part D appeal path on that notice.

Can I get a 90-day supply of Wegovy? Several GEHA plans include 90-day mail service, and the public Caremark policy lists three-month quantity limits for Wegovy products. That still does not guarantee your exact product can be filled for 90 days under your plan. Elevate has no mail service. Confirm with Caremark before changing the prescription.

Does insurance coverage mean Wegovy is right for me? No. Coverage and medical appropriateness are two different decisions. Only a licensed clinician who knows your full history can make the second one.

The bottom line

GEHA covers the standard Wegovy injection in 2026 on all eight regular plan options when prior authorization is approved. That part isn't in doubt — GEHA wrote it down.

What changed is the tier on High, Standard, HDHP, and Elevate Plus, and the difference can be real money. But you have more control than the situation suggests:

1. Look up your plan-specific estimate in the correct GEHA/Caremark tool. Free.
2. Enroll in the manufacturer savings offer if you validly qualify. Eligible one-month claims can save up to $100; eligible three-month claims can save up to $300. Free.
3. Ask about a 90-day supply if your plan and exact product allow it. The published maximum-only difference can reach $1,600–$2,200 a year on FEHB High and Standard, but confirm eligibility before you count it. The check is free.
4. Put the six months of required program records in front of your prescriber before the PA goes in. Complete records can be the difference between a clean review and a preventable denial. Start free by asking what is already in your chart.

Four moves. Each starts with a free step.

Still not sure which GLP-1 program is right for you? Take our free 60-second matching quiz.

Sources

All sources below were read directly and checked on August 19, 2026.

1. GEHA, Pharmacy coverage for weight loss GLP-1 medications, document FE-WEB-1225-001
2. GEHA, Check Drug Costs
3. GEHA 2026 FEHB plan pages: Elevate, HDHP, Standard, Elevate Plus, High
4. GEHA 2026 PSHB plan pages: HDHP, Standard, High
5. GEHA 2026 plan brochures: FEHB High and Standard, RI 71-006, FEHB HDHP, RI 71-014, FEHB Elevate and Elevate Plus, RI 71-018, PSHB High and Standard, RI 71-021, PSHB HDHP
6. CVS Caremark, Wegovy Prior Authorization with Limit, document 4774-C, P08-2025 v4
7. CVS Caremark, GEHA traditional formulary and GEHA value formulary
8. GEHA, Appeal Process and Disputed Claims FAQs
9. GEHA, MDLIVE telehealth costs
10. GEHA, Prescription Drug Plan/EGWP
11. Novo Nordisk, Wegovy savings-offer terms and official self-pay prices
12. CMS, Medicare GLP-1 Bridge and prescriber instructions
13. OPM, Open Season date rule
14. FDA, Compounded drugs are not FDA-approved and rules against calling compounded GLP-1 drugs generic or the same as FDA-approved drugs
15. Ro, free GLP-1 Insurance Coverage Checker and Ro Body program

The RX Index is the independent GLP-1 decision resource that scores telehealth providers and treatment paths on clinical legitimacy, care quality, transparency, access, and cost, so readers can choose the path that fits their situation.

This article is general information, not medical advice. It doesn't replace your plan brochure, formulary, approval or denial notice, Caremark or SilverScript account, processed claim, or clinician. Verify your own product and numbers before you budget on them.

By The RX Index · Last verified: August 19, 2026 · Next scheduled price check: August 31, 2026 · Full review: October 2026, before Open Season